Meta-analysis and Systematic Review of Bronchoscopic Lung Volume Reduction Through Endobronchial Valves in Severe Emphysema

Background: Pharmacologic therapeutics for advanced emphysema have limited benefit. Bronchoscopic lung volume reduction with endobronchial valves (EBVs) have reported improvements in lung function, breathlessness, and quality of life through randomized clinical trials, with less morbidity as comparted to Surgical Lung volume Reduction. We here present a Meta-analysis and systematic review of bronchoscopic lung volume reduction in advanced chronic obstructive lung disease patients Methods: PubMed (NLM), Embase (Elsevier), and Web of Science (Clarivate Analytics) search was conducted using a combination of keywords and subject headings. The search was confined to the last 15 years and was completed on October 23, 2020. Only placebo-controlled randomized control trials of emphysema patients with EBV were included. Quality assessment was done by 2 independent reviewers. Results: Nine studies were included for the meta-analysis with a total number of 1383 patients of whom 888 received EBV and 495 standard of care (SOC) medications. Our Metanalysis show statistically significant improvement in forced expiratory volume in first second, percentage forced expiratory volume in first second, St. George’s respiratory questionnaire, and 6-minute walk distance in EBV group compared with SOC. Residual volume had statistically significant reduction after EBV placement compared with SOC. These differences continued to be present during short-term (<=6 mo) and long-term follow-up (>=6 mo). These improvements were even higher when the EBV patients’. Collateral ventilation was negative/fissure was intact (CV−/FI >90%). The rate of hemoptysis and pneumothorax was higher in the EBV group compared with SOC, however, did not lead to increased fatal outcomes. Conclusion: In conclusion, EBV has favorable effects on patients’ outcomes in patients who have heterogeneous emphysema particularly with no collateral ventilation.

[1]  D. Slebos,et al.  Endobronchial valve therapy for severe emphysema: an overview of valve-related complications and its management , 2020, Expert review of respiratory medicine.

[2]  Alyssa R Goldbach,et al.  Role of Imaging in Bronchoscopic Lung Volume Reduction Using Endobronchial Valve: State of the Art Review. , 2020, Journal of thoracic imaging.

[3]  G. Criner,et al.  Bronchoscopic lung volume reduction: status quo , 2020, Annals of translational medicine.

[4]  D. Slebos,et al.  An Integrative Approach of the Fissure Completeness Score and Chartis Assessment in Endobronchial Valve Treatment for Emphysema , 2020, International journal of chronic obstructive pulmonary disease.

[5]  M. Wahidi,et al.  Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year. Results from a Randomized Clinical Trial , 2020, Annals of the American Thoracic Society.

[6]  D. Slebos,et al.  Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO , 2020, Respiration.

[7]  K. Darwiche,et al.  Predictive value of Chartis measurement for lung function improvements in bronchoscopic lung volume reduction , 2020, Therapeutic advances in respiratory disease.

[8]  S. Makani,et al.  Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial , 2019, American journal of respiratory and critical care medicine.

[9]  F. Herth,et al.  Efficacy of the Spiration Valve System in Patients with Severe Heterogeneous Emphysema: A Systematic Review and Meta-Analysis , 2019, Respiration.

[10]  A. Ricci,et al.  Functional benefit of smoking cessation in severe COPD patients undergoing bronchial valve implantation. , 2019, European journal of internal medicine.

[11]  F. Herth,et al.  Long-term follow up after endoscopic valve therapy in patients with severe emphysema , 2019, Therapeutic advances in respiratory disease.

[12]  Jae Seung Lee,et al.  Clinical Utility of Quantitative CT Analysis for Fissure Completeness in Bronchoscopic Lung Volume Reduction: Comparison between CT and Chartis™ , 2019, Korean journal of radiology.

[13]  J. Mortensen,et al.  Lobar Quantification by Ventilation/Perfusion SPECT/CT in Patients with Severe Emphysema Undergoing Lung Volume Reduction with Endobronchial Valves , 2019, Respiration.

[14]  F. Herth,et al.  Bronchoscopic Lung Volume Reduction with Endobronchial Zephyr Valves for Severe Emphysema: A Systematic Review and Meta-Analysis , 2019, Respiration.

[15]  Guang-Zhong Yang,et al.  Role of Quantitative Computed Tomographic Scan Analysis in Lung Volume Reduction for Emphysema , 2019, Respiration.

[16]  Chiu-Hsieh Hsu,et al.  Endobronchial Valves Therapy for Advanced Emphysema: A Meta-Analysis of Randomized Trials , 2019, Journal of bronchology & interventional pulmonology.

[17]  R. Huebner,et al.  Selecting Patients for Lobar Lung Volume Reduction Therapy: What Quantitative Computed Tomography Parameters Matter? , 2018, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[18]  F. Venuta,et al.  Visual analysis versus quantitative CT analysis of interlobar fissure integrity in selecting emphysematous patients for endobronchial valve treatment. , 2018, Interactive cardiovascular and thoracic surgery.

[19]  C. Bai,et al.  The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema , 2018, Respiration.

[20]  M. Vitacca,et al.  Additive effect on pulmonary function and disability of intensive pulmonary rehabilitation following bronchoscopy lung volume reduction (BLVR) for severe emphysema. , 2018, Respiratory medicine.

[21]  F. Herth,et al.  Long-term follow-up after endoscopic valve therapy in patients with severe emphysema , 2018, Interventional Pulmonology.

[22]  Zhixin Liang,et al.  The safety and efficacy of endobronchialvalve therapy in patients with advanced heterogeneous emphysema versus standard medical care , 2018, Medicine.

[23]  A. Sung,et al.  A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE) , 2018, American journal of respiratory and critical care medicine.

[24]  F. Venuta,et al.  Complications related to endoscopic lung volume reduction for emphysema with endobronchial valves: results of a multicenter study. , 2018, Journal of thoracic disease.

[25]  B. Gärtner,et al.  Microbiological airway colonization in COPD patients with severe emphysema undergoing endoscopic lung volume reduction , 2017, International journal of chronic obstructive pulmonary disease.

[26]  F. Herth,et al.  New bacterial growth in bronchial secretions after bronchoscopic valve implantation , 2017, International Journal of COPD.

[27]  A. Ing,et al.  Endoscopic Lung Volume Reduction in COPD: Improvements in Gas Transfer Capacity Are Associated With Improvements in Ventilation and Perfusion Matching , 2018, Journal of bronchology & interventional pulmonology.

[28]  G. Hillerdal,et al.  A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM) , 2017, American journal of respiratory and critical care medicine.

[29]  A. Fiorelli,et al.  Bronchoscopic lung volume reduction with endobronchial valves for heterogeneous emphysema: long-term results. , 2017, Journal of visualized surgery.

[30]  D. Slebos,et al.  Pleural Adhesion Assessment as a Predictor for Pneumothorax after Endobronchial Valve Treatment , 2017, Respiration.

[31]  Jae Seung Lee,et al.  Improvement in Ventilation-Perfusion Mismatch after Bronchoscopic Lung Volume Reduction: Quantitative Image Analysis. , 2017, Radiology.

[32]  D. Slebos,et al.  Improved Predictors of Survival after Endobronchial Valve Treatment in Patients with Severe Emphysema. , 2017, American journal of respiratory and critical care medicine.

[33]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary , 2017, European Respiratory Journal.

[34]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. , 2017, American journal of respiratory and critical care medicine.

[35]  R. Eberhardt,et al.  Clinical and radiological outcome following pneumothorax after endoscopic lung volume reduction with valves , 2016, International journal of chronic obstructive pulmonary disease.

[36]  K. Darwiche,et al.  Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Low-FEV1 Patients , 2016, Respiration.

[37]  F. Herth,et al.  Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study. , 2016, American journal of respiratory and critical care medicine.

[38]  R. Bals,et al.  Endoscopic Lung Volume Reduction Using Endobronchial Valves in Patients with Severe Emphysema and Very Low FEV1 , 2016, Respiration.

[39]  E. V. van Rikxoort,et al.  Predicting Lung Volume Reduction after Endobronchial Valve Therapy Is Maximized Using a Combination of Diagnostic Tools , 2016, Respiration.

[40]  D. Hansell,et al.  Survival after Endobronchial Valve Placement for Emphysema: A 10-Year Follow-up Study. , 2016, American journal of respiratory and critical care medicine.

[41]  F. Herth,et al.  Predictors of pneumothorax following endoscopic valve therapy in patients with severe emphysema , 2016, International journal of chronic obstructive pulmonary disease.

[42]  R. Hubner,et al.  Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy , 2016, International journal of chronic obstructive pulmonary disease.

[43]  The Role of Lobe Selection on FEV1 Response in Endobronchial Valve Therapy , 2016, COPD.

[44]  R. Huebner,et al.  Outcomes of Endobronchial Valve Treatment Based on the Precise Criteria of an Endobronchial Catheter for Detection of Collateral Ventilation under Spontaneous Breathing , 2015, Respiration.

[45]  E. V. van Rikxoort,et al.  Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation. , 2015, The New England journal of medicine.

[46]  Daniela Gompelmann,et al.  Endoscopic bronchial valve treatment: patient selection and special considerations , 2015, International journal of chronic obstructive pulmonary disease.

[47]  F. Herth,et al.  Comparing Clinical Outcomes in Upper versus Lower Lobe Endobronchial Valve Treatment in Severe Emphysema , 2015, Respiration.

[48]  D. Hansell,et al.  A randomised controlled study of Bronchoscopic Lung Volume Reduction with endobronchial valves for patients with Heterogeneous emphysema and Intact interlobar Fissures: the BeLieVeR-HIFi study , 2015 .

[49]  R. Whyte,et al.  The accuracy of computed tomography to predict completeness of pulmonary fissures. A prospective study. , 2015, Annals of the American Thoracic Society.

[50]  Ipek Oguz,et al.  Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. , 2015, American journal of respiratory and critical care medicine.

[51]  R. Fimmers,et al.  Effect of Endobronchial Valve Therapy on Pulmonary Perfusion and Ventilation Distribution , 2015, PloS one.

[52]  Matthew S. Brown,et al.  Diagnostic performance comparison of the Chartis System and high‐resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction , 2014, Respirology.

[53]  G. Criner,et al.  Pneumothorax following Endobronchial Valve Therapy and Its Impact on Clinical Outcomes in Severe Emphysema , 2014, Respiration.

[54]  A. Fiorelli,et al.  Quantitative assessment of emphysematous parenchyma using multidetector-row computed tomography in patients scheduled for endobronchial treatment with one-way valves†. , 2013, Interactive cardiovascular and thoracic surgery.

[55]  G. Criner,et al.  Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy , 2013, European Respiratory Journal.

[56]  T. Gislason,et al.  The impact of COPD on health status: findings from the BOLD study , 2013, European Respiratory Journal.

[57]  J. Goldin,et al.  Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. , 2011, Chest.

[58]  F. Herth,et al.  Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment , 2012, European Respiratory Journal.

[59]  M. Noppen,et al.  Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort , 2012, European Respiratory Journal.

[60]  P. Shekelle,et al.  Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society , 2011, Annals of Internal Medicine.

[61]  D. Hansell,et al.  Atelectasis and survival after bronchoscopic lung volume reduction for COPD , 2010, European Respiratory Journal.

[62]  G. McLennan,et al.  A randomized study of endobronchial valves for advanced emphysema. , 2010, The New England journal of medicine.

[63]  R. Hoogenveen,et al.  Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach , 2010, European Respiratory Journal.

[64]  F. Venuta,et al.  Computed tomography with volume rendering for the evaluation of parenchymal hyperinflation after bronchoscopic lung volume reduction. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[65]  S. Cogswell,et al.  Computed tomography assessment of lung volume changes after bronchial valve treatment , 2008, European Respiratory Journal.

[66]  T. Gildea,et al.  A multicenter trial of an intrabronchial valve for treatment of severe emphysema. , 2007, Journal of Thoracic and Cardiovascular Surgery.

[67]  G. Snell,et al.  133Xenon ventilation scintigraphy applied to bronchoscopic lung volume reduction techniques for emphysema: relevance of interlobar collaterals , 2005, Internal medicine journal.

[68]  D. Sugarbaker,et al.  Lung volume reduction surgery for emphysema. , 1996, Chest.

[69]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.